» Authors » Daniele Dubois-Laforgue

Daniele Dubois-Laforgue

Explore the profile of Daniele Dubois-Laforgue including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 31
Citations 816
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Diedisheim M, Mallone R, Pugliese A, Dubois-Laforgue D, Larger E
J Clin Endocrinol Metab . 2025 Jan; PMID: 39873482
Context: Type 1 diabetes (T1D) is characterized by the presence of autoantibodies on a genetic background largely determined by HLA class II haplotypes. Stage 1 T1D is characterized by the...
2.
Vermillac G, Lafont C, Godot C, Kerbourch S, Gazagnes A, Mosnier-Pudar H, et al.
Diabetes Obes Metab . 2025 Jan; 27(3):1397-1405. PMID: 39764706
Background: Transition from paediatric to adult healthcare is a turning point for patients with Type 1 diabetes (T1D). A gradual coordinated process connecting paediatric and adult healthcare providers may improve...
3.
Alexandre-Heymann L, Yaker F, Bel Lassen P, Dubois-Laforgue D, Larger E
Diabetol Metab Syndr . 2024 Feb; 16(1):39. PMID: 38331895
Background: Exocrine pancreatic insufficiency (EPI) can be associated with all types of diabetes. Pancreatic enzyme replacement therapy (PERT) has short and long-term benefits in subjects with EPI, but its effects...
4.
Francis Y, Tiercelin C, Alexandre-Heyman L, Larger E, Dubois-Laforgue D
J Endocr Soc . 2022 Jun; 6(8):bvac087. PMID: 35733830
Hepatocyte nuclear factor-1B (HNF1B) maturity-onset diabetes of the young (MODY), also referred to as "renal cysts and diabetes syndrome" or MODY-5, is a rare form of monogenic diabetes that is...
5.
Timsit J, Ciangura C, Dubois-Laforgue D, Saint-Martin C, Bellanne-Chantelot C
Front Endocrinol (Lausanne) . 2022 Jan; 12:802423. PMID: 35069449
Heterozygous loss-of-function variants of the glucokinase () gene are responsible for a subtype of maturity-onset diabetes of the young (MODY). -MODY is characterized by a mild hyperglycemia, mainly due to...
6.
Azoury M, Tarayrah M, Afonso G, Pais A, Colli M, Maillard C, et al.
Diabetes . 2020 Sep; 69(12):2678-2690. PMID: 32928873
The antigenic peptides processed by β-cells and presented through surface HLA class I molecules are poorly characterized. Each HLA variant (e.g., the most common being HLA-A2 and HLA-A3) carries some...
7.
Donath X, Saint-Martin C, Dubois-Laforgue D, Rajasingham R, Mifsud F, Ciangura C, et al.
BMC Med . 2019 Jul; 17(1):132. PMID: 31291970
Background: Monogenic diabetes (MgD) accounts for 1-2% of all diabetes cases. In adults, MgD is difficult to distinguish from common diabetes causes. We assessed the diagnosis rate and genetic spectrum...
8.
Gonzalez-Duque S, Azoury M, Colli M, Afonso G, Turatsinze J, Nigi L, et al.
Cell Metab . 2018 Aug; 28(6):946-960.e6. PMID: 30078552
Although CD8 T-cell-mediated autoimmune β cell destruction occurs in type 1 diabetes (T1D), the target epitopes processed and presented by β cells are unknown. To identify them, we combined peptidomics...
9.
10.
Dubois-Laforgue D
Nephrol Ther . 2017 Jun; 13 Suppl 1:S137-S146. PMID: 28577736
Post-transplantation diabetes mellitus is defined as diabetes that is diagnosed in grafted patients. It affects 20 to 30 % of kidney transplant recipients, with a high incidence in the first...